-+ 0.00%
-+ 0.00%
-+ 0.00%

Bristol Myers Squibb Reports Promising Phase 2 Results for Pumitamig in Advanced Triple-Negative Breast Cancer

路透·12/09/2025 12:08:04

登录查看新闻详情